Literature DB >> 4040217

Chlorimipramine, electroconvulsive shock and combination thereof: differential effects of chronic treatment on apomorphine-induced behaviours and on striatal and mesocortical dopamine turnover.

C Spyraki, Z Papadopoulou, A Kourkoubas, D Varonos.   

Abstract

We studied the influence of different pretreatment regimens (Chlorimipramine-Cmi, electroconvulsive shock-ECS, and Cmi + ECS all regimens being applied for either 2 or 15 days) on the open field behaviour, on the striatal and on the prefrontal dopamine-PFC DA turnover in rats injected with either apomorphine-AP 25 micrograms/kg (stimulating presynaptic DA receptors), AP 200 micrograms/kg (stimulating post-synaptic DA receptors), or vehicle (control). In the controls, AP 25 micrograms/kg reduced the locomotor activity and the striatal, but not the PFC DA turnover. AP 200 micrograms/kg increased the locomotor activity and reduced the striatal but not the PFC DA turnover. Short-term pretreatment: ECS and Cmi + ECS prevented the decrease of striatal DA turnover after AP 25 micrograms/kg. No other influence of any pretreatment on behaviour or DA-turnover became significant. Long-term pretreatment: Chronic Cmi: marginally increased the open field behaviour and marginally decreased the PFC DA turnover; significantly increased the effect of AP (200 micrograms/kg) on striatal DA turnover and the effect of AP (25 and 200 micrograms/kg) on PFC DA turnover. Repeated ECS: decreased locomotion and rearing and increased PFC DA turnover; increased the effect of AP (200 micrograms/kg) on locomotion and on striatal DA turnover; decreased the effect of AP (25 and 200 micrograms/kg) on PFC DA turnover. Chronic Cmi + ECS: decreased locomotion and rearing and marginally decreased PFC DA turnover; increased the effect of AP on hyperlocomotion and on striatal DA turnover.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040217     DOI: 10.1007/bf00501201

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat.

Authors:  C J Pycock; C J Carter; R W Kerwin
Journal:  J Neurochem       Date:  1980-01       Impact factor: 5.372

2.  Effects of antidepressant drugs on dopamine uptake and metabolism.

Authors:  P C Waldmeier
Journal:  J Pharm Pharmacol       Date:  1982-06       Impact factor: 3.765

3.  Increased sensitivity to (+)amphetamine self-administered by rats following meso-cortico-limbic dopamine neurone destruction.

Authors:  M Le Moal; L Stinus; H Simon
Journal:  Nature       Date:  1979-07-12       Impact factor: 49.962

4.  Chronic treatment with antidepressant drugs: potentiation of apomorphine-induced aggressive behaviour in rats.

Authors:  J Maj; E Mogilnicka; A Kordecka
Journal:  Neurosci Lett       Date:  1979-08       Impact factor: 3.046

5.  Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in rats.

Authors:  M Wielosz
Journal:  Neuropharmacology       Date:  1981-10       Impact factor: 5.250

6.  Cortical modulation of striatal function.

Authors:  B Scatton; P Worms; K G Lloyd; G Bartholini
Journal:  Brain Res       Date:  1982-01-28       Impact factor: 3.252

7.  Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat.

Authors:  J P Tassin; L Stinus; H Simon; G Blanc; A M Thierry; M Le Moal; B Cardo; J Glowinski
Journal:  Brain Res       Date:  1978-02-10       Impact factor: 3.252

8.  Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.

Authors:  P H Kelly; P W Seviour; S D Iversen
Journal:  Brain Res       Date:  1975-09-05       Impact factor: 3.252

9.  Striatal dopamine autoreceptors uninfluenced by chronic administration of antidepressants.

Authors:  H H Holcomb; M J Bannon; R H Roth
Journal:  Eur J Pharmacol       Date:  1982-08-27       Impact factor: 4.432

10.  Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.

Authors:  C J Carter; C J Pycock
Journal:  Brain Res       Date:  1980-06-16       Impact factor: 3.252

View more
  2 in total

1.  Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens.

Authors:  J C Barnes; B Costall; A M Domeney; R J Naylor
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Effects of acute and chronic desipramine treatment on somatostatin receptors in brain.

Authors:  E G Gheorvassaki; K Thermos; G Liapakis; C Spyraki
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.